Overview
Roland Soldner-Wedlich practices practicing medicine in Muenster, Germany.
His clinical expertise encompasses Denys-Drash Syndrome (DDS) and Focal Segmental Glomerulosclerosis.
He is actively involved in clinical research, co-authoring 44 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Roland Soldner-Wedlich
Is Roland Soldner-Wedlich a top-rated expert for Denys-Drash Syndrome (DDS)?
MediFind is an objective health platform that identifies experts based on real-world data. Roland Soldner-Wedlich is classified as an Experienced expert for Denys-Drash Syndrome (DDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Roland Soldner-Wedlich participate in research or clinical trials?
Yes. Roland Soldner-Wedlich has published 44 articles and abstracts on conditions like Denys-Drash Syndrome (DDS). You can view a list of Roland Soldner-Wedlich's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Denys-Drash Syndrome (DDS)Mr. Soldner-Wedlich isExperienced. Learn about Denys-Drash Syndrome (DDS).
- Focal Segmental GlomerulosclerosisMr. Soldner-Wedlich isExperienced. Learn about Focal Segmental Glomerulosclerosis.